Sign in
4

Changes in Ownership

Aquestive Therapeutics, Inc. Filed Acc 0001214659-23-006559

Options or other derivatives

  • SVP, Chief Financial Officer acquired 70,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

TOTH A ERNEST JR · SVP, Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-05-05 Grant or award : show line 1 in the form Performance Stock Units +70,000 70,000 D
Loading xslF345X04/marketforms-61241.xml…